Trial ChiCTR2000031809
Publication Guo W, EClinicalMedicine, 2021
Primary outcome on the report: 7-day adverse reactions; neutralizing antibody titres and specific IgG binding antibody titres measured on days 28 and 90 after the whole-course vaccination

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.